Where To Get Allergy Shots: Clinic Types, Access, and Costs

Yes — a primary-care physician can administer allergy shots prescribed and formulated by a board-certified allergist, provided the primary-care office maintains the required emergency equipment (epinephrine, resuscitation supplies) and follows the allergist's protocol. This arrangement is less common than receiving shots directly from the allergist but is allowable per Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55). The prescribing allergist must review and sign off on the patient's extract formulation and dose schedule. The 30-minute observation requirement applies regardless of which clinical setting administers the shot. Some patients prefer this model if their primary-care office is geographically closer than the allergist's practice, though it does require the allergist to coordinate remotely.

The American Academy of Allergy, Asthma and Immunology (AAAAI) maintains a Find an Allergist directory at aaaai.org that searches by zip code, insurance plan, and specialty focus. The American Board of Allergy and Immunology (ABAI) also maintains a board-certification verification tool. Both are free. When reviewing a result, confirm the location is a freestanding allergist office rather than a hospital-affiliated outpatient department — the clinical care is identical but the billing classification determines facility fees. Per Wu I et al. (AAAAI 2019), 81.5% of US counties have zero practicing allergists, so rural patients may need to search within a 50-100 mile radius. Telemedicine consultations for the initial evaluation are increasingly available and do not require the same geographic proximity, though the injections themselves must still be administered in person.

Hospital outpatient departments (HOPDs) are authorized by CMS to bill a "facility fee" on top of the physician fee for any procedure — including allergy shots — because they are classified as hospital services rather than freestanding clinic services. The same CPT 95117 injection that generates a $11.97 Medicare-allowed physician fee generates a separate HOPD facility fee that can total hundreds of dollars per visit. The clinical procedure is identical; only the billing classification differs. The PBS NewsHour Weekend 2024 investigation documented one patient (Kaitlin Johnson, M Health Fairview MN) who was billed $24,400 for a 40-allergen evaluation and initiation that surrounding freestanding clinics quoted at $800–$1,827. Patients can avoid this by asking before scheduling whether the practice site is classified as a hospital outpatient department.

Allergy shots require access to epinephrine, a post-injection observation window, and an ongoing board-certified allergist relationship — not a one-time drop-in visit (Cox L et al., J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, Summary Statement 32). Urgent-care centers are not set up to formulate patient-specific immunotherapy vials or provide the required ongoing allergist oversight; a walk-in urgent care is not a valid SCIT setting. The ongoing dose escalation and safety monitoring require a prescribing allergist who has formulated the patient-specific extract and established the dose schedule. Traditional settings include a board-certified allergist's freestanding office or a primary-care office under the allergist's delegated protocol. Curex's at-home SCIT program meets these requirements through a different delivery model: a telehealth consultation with a board-certified allergist, a personalized serum sterile-compounded to USP <797> standards, the first dose and every dose change supervised live over Zoom, and a prescribed epinephrine auto-injector confirmed on hand — making structured, supervised SCIT available without a physical office visit.

Unmonitored home self-administration of allergy shots — without a prescribed epinephrine auto-injector on hand and without physician oversight — is not a safe approach, and UnitedHealthcare ended coverage of unsupervised home SCIT effective January 1, 2023. The clinical rationale is sound: severe systemic reactions, though rare at 0.1% per injection visit, require immediate epinephrine access, and approximately 70% of severe reactions begin within 30 minutes of injection (Cox L et al., J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55). Curex's at-home SCIT program ($129/mo) is built around that exact safety logic: a prescribed epinephrine auto-injector confirmed on hand before the first injection, the first dose and every dose change supervised live over Zoom by the prescribing physician, USP <797> sterile-compounded personalized serum, gradual week-by-week escalation, and board-certified allergist oversight throughout. Legacy health plans may still permit home administration in limited circumstances — verify current plan language; Curex's care team can help navigate coverage.

Medicaid coverage of allergy shots varies dramatically by state. Ho FO, Bilaver LA et al. (Am J Manag Care 2024;30[8]:374-379, DOI 10.37765/ajmc.2024.89588) found state-level Medicaid acceptance among practicing allergists ranges from 13.4% in New York to 72.3% in California — meaning in some states the majority of board-certified allergists do not accept Medicaid patients even when the service is technically a covered benefit. CMS LCD L36240 designates allergen immunotherapy as a covered Medicare benefit under specific criteria; Medicaid coverage follows state plans that typically mirror this. Patients on Medicaid should contact individual allergist offices directly to confirm acceptance before scheduling, and should ask about wait times, which can be longer for Medicaid patients in states with low participation rates.